NASDAQ:NVCT
Nuvectis Pharma, Inc. Stock Company Profile
$7.56
-0.580 (-7.13%)
At Close: May 06, 2024
Information
1 Bridge Plaza, Suite 275
Fort Lee NJ 07024
201 614 3150
www.nuvectis.com
Industry: Biotechnology
Sector: Healthcare
Description
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.